Rimidi and Eli Lilly and Company are partnering to develop provider-focused tools that will integrate personalized solutions for people who use insulin to manage their diabetes. Under the partnership, Rimidi will integrate its diabetes management software platform with Lilly’s integrated insulin management system in development.   The non-exclusive agreement will aim to make diabetes management easier for the approximately 30 million Americans by helping people use insulin more eff...